Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Strobl

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|September 26, 2025
Evolutionary antifragile therapyJeffrey West, Bina Desai, Maximilian Strobl, et al.
Cancer Research|May 19, 2023
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling DynamicsJill Gallaher, Maximilian Strobl, Jeffrey West, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor schedulingMaximilian Strobl, Alexandra L Martin, Jeffrey West, et al.
Elife|March 23, 2023
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translationJeffrey West, Fred Adler, Jill Gallaher, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
75 Years of Mathematical OncologyFranco Pradelli, Maximilian Strobl, Sadegh Marzban, et al.
Nature Communications|April 5, 2022
Immunosuppressive niche engineering at the onset of human colorectal cancerChandler D Gatenbee, Ann-Marie Baker, Ryan O Schenck, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|September 26, 2025
Evolutionary antifragile therapyJeffrey West, Bina Desai, Maximilian Strobl, et al.
Cancer Research|May 19, 2023
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling DynamicsJill Gallaher, Maximilian Strobl, Jeffrey West, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor schedulingMaximilian Strobl, Alexandra L Martin, Jeffrey West, et al.
Elife|March 23, 2023
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translationJeffrey West, Fred Adler, Jill Gallaher, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
75 Years of Mathematical OncologyFranco Pradelli, Maximilian Strobl, Sadegh Marzban, et al.
Nature Communications|April 5, 2022
Immunosuppressive niche engineering at the onset of human colorectal cancerChandler D Gatenbee, Ann-Marie Baker, Ryan O Schenck, et al.
Pageof 1